Global Hereditary Angioedema Therapeutic Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID :GIR-14765471 | Published Date: 11-Dec-2019 | No. of pages: 105Description
TOC
Table of Contents
1 Hereditary Angioedema Therapeutic Market Overview
1.1 Product Overview and Scope of Hereditary Angioedema Therapeutic
1.2 Classification of Hereditary Angioedema Therapeutic by Types
1.2.1 Global Hereditary Angioedema Therapeutic Revenue Comparison by Types (2019-2024)
1.2.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018
1.2.3 Intravenous
1.2.4 Subcutaneous
1.2.5 Oral
1.3 Global Hereditary Angioedema Therapeutic Market by Application
1.3.1 Global Hereditary Angioedema Therapeutic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Hereditary Angioedema Therapeutic Market by Regions
1.4.1 Global Hereditary Angioedema Therapeutic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hereditary Angioedema Therapeutic Status and Prospect (2014-2024)
1.5 Global Market Size of Hereditary Angioedema Therapeutic (2014-2024)
2 Company Profiles
2.1 BioCryst Pharma
2.1.1 Business Overview
2.1.2 Hereditary Angioedema Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.2 KalVista Pharma
2.2.1 Business Overview
2.2.2 Hereditary Angioedema Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Limited
2.3.1 Business Overview
2.3.2 Hereditary Angioedema Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.4 Ionis Pharma
2.4.1 Business Overview
2.4.2 Hereditary Angioedema Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Adverum Biotechnologies
2.5.1 Business Overview
2.5.2 Hereditary Angioedema Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pharming Group
2.6.1 Business Overview
2.6.2 Hereditary Angioedema Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.7 Attune Pharma
2.7.1 Business Overview
2.7.2 Hereditary Angioedema Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Shire
2.8.1 Business Overview
2.8.2 Hereditary Angioedema Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Hereditary Angioedema Therapeutic Market Competition, by Players
3.1 Global Hereditary Angioedema Therapeutic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Hereditary Angioedema Therapeutic Players Market Share
3.2.2 Top 10 Hereditary Angioedema Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global Hereditary Angioedema Therapeutic Market Size by Regions
4.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Regions
4.2 North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
4.3 Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
4.5 South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
5 North America Hereditary Angioedema Therapeutic Revenue by Countries
5.1 North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
5.2 USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
5.3 Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
5.4 Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
6 Europe Hereditary Angioedema Therapeutic Revenue by Countries
6.1 Europe Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
6.2 Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
6.3 UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
6.4 France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
6.5 Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
6.6 Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries
7.1 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
7.2 China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
7.3 Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
7.4 Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
7.5 India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
8 South America Hereditary Angioedema Therapeutic Revenue by Countries
8.1 South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
8.2 Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
8.3 Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
8.4 Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Hereditary Angioedema Therapeutic by Countries
9.1 Middle East and Africa Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
9.3 UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
9.4 Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
9.6 South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
10 Global Hereditary Angioedema Therapeutic Market Segment by Type
10.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Type (2014-2019)
10.2 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2019-2024)
10.3 Intravenous Revenue Growth Rate (2014-2024)
10.4 Subcutaneous Revenue Growth Rate (2014-2024)
10.5 Oral Revenue Growth Rate (2014-2024)
11 Global Hereditary Angioedema Therapeutic Market Segment by Application
11.1 Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2014-2019)
11.2 Hereditary Angioedema Therapeutic Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)
12.1 Global Hereditary Angioedema Therapeutic Market Size Forecast (2019-2024)
12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Regions (2019-2024)
12.3 North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
12.4 Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
12.6 South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Hereditary Angioedema Therapeutic Picture
Table Product Specifications of Hereditary Angioedema Therapeutic
Table Global Hereditary Angioedema Therapeutic and Revenue (Million USD) Market Split by Product Type
Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Types in 2018
Figure Intravenous Picture
Figure Subcutaneous Picture
Figure Oral Picture
Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Application (2014-2024)
Figure Hereditary Angioedema Therapeutic Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Hereditary Angioedema Therapeutic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (2014-2024)
Table BioCryst Pharma Basic Information, Manufacturing Base and Competitors
Table BioCryst Pharma Hereditary Angioedema Therapeutic Type and Applications
Table BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table KalVista Pharma Basic Information, Manufacturing Base and Competitors
Table KalVista Pharma Hereditary Angioedema Therapeutic Type and Applications
Table KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Hereditary Angioedema Therapeutic Type and Applications
Table CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Ionis Pharma Basic Information, Manufacturing Base and Competitors
Table Ionis Pharma Hereditary Angioedema Therapeutic Type and Applications
Table Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Adverum Biotechnologies Basic Information, Manufacturing Base and Competitors
Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Type and Applications
Table Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Pharming Group Basic Information, Manufacturing Base and Competitors
Table Pharming Group Hereditary Angioedema Therapeutic Type and Applications
Table Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Attune Pharma Basic Information, Manufacturing Base and Competitors
Table Attune Pharma Hereditary Angioedema Therapeutic Type and Applications
Table Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Hereditary Angioedema Therapeutic Type and Applications
Table Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2017-2018)
Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Players (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue Share by Players (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2017
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2018
Figure Global Top 5 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018
Figure Global Top 10 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2018
Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Regions (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Market Share by Regions in 2018
Figure North America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Europe Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure South America Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table North America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
Table North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure North America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018
Figure USA Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table Europe Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Europe Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018
Figure Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure UK Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018
Figure China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table South America Hereditary Angioedema Therapeutic Revenue by Countries (2014-2019)
Table South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure South America Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018
Figure Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Colombia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Countries in 2018
Figure Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Egypt Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure Nigeria Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Figure South Africa Hereditary Angioedema Therapeutic Revenue and Growth Rate (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) by Type (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Type in 2018
Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Type (2019-2024)
Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2019-2024)
Figure Global Intravenous Revenue Growth Rate (2014-2019)
Figure Global Subcutaneous Revenue Growth Rate (2014-2019)
Figure Global Oral Revenue Growth Rate (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue by Application (2014-2019)
Table Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue Share by Application in 2018
Table Global Hereditary Angioedema Therapeutic Revenue Forecast by Application (2019-2024)
Figure Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Hereditary Angioedema Therapeutic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Hereditary Angioedema Therapeutic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Hereditary Angioedema Therapeutic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
Figure Europe Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
Figure South America Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Forecast (2019-2024)
Companies
BioCryst Pharma
KalVista Pharma
CSL Limited
Ionis Pharma
Adverum Biotechnologies
Pharming Group
Attune Pharma
Shire
- PRICE
-
$3480$6960